Proteome expression database of ewing sarcoma: A segment of the genome medicine database of Japan proteomics

Kazutaka Kikuta, Yukako Tsunehiro, Akihiko Yoshida, Naobumi Tochigi, Setsuo Hirohahsi, Akira Kawai, Tadashi Kondo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Ewing sarcoma is the second most common primary malignant bone tumor in children and adolescents worldwide. Here, we report an open-access proteome expression database of eight Ewing sarcoma cases using proteome data obtained by two-dimensional difference gel electrophoresis (2D-DIGE) and mass spectrometry. Proteins extracted from primary tumor tissues were labeled with CyDye DIGE Fluor saturation dye, and separated using a large format electrophoresis device, generating 2431 protein spots. Mass spectrometry following in-gel digestion identified 330 protein spots corresponding to 220 proteins. Multiple proteins were observed from single protein spots, and single proteins generated multiple protein spots, suggesting diversity of the proteome observed by 2D-DIGE. The results of 2D-DIGE and protein identification by mass spectrometry, and part of the corresponding clinico-pathological data such as prognosis after treatments are freely accessible in the public proteome database Genome Medicine Database of Japan Proteomics (GeMDBJ Proteomics, https://gemdbj.nibio.go.jp/dgdb/DigeTop.do).

Original languageEnglish
Pages (from-to)500-504
Number of pages5
JournalJournal of Proteomics and Bioinformatics
Volume2
Issue number12
DOIs
Publication statusPublished - 2009
Externally publishedYes

Fingerprint

Ewing's Sarcoma
Proteome
Proteomics
Medicine
Japan
Genes
Genome
Databases
Proteins
Two-Dimensional Difference Gel Electrophoresis
Mass spectrometry
Mass Spectrometry
Electrophoresis
Tumors
Gels
Digestion
Neoplasms
Bone
Coloring Agents
Tissue

Keywords

  • Ewing sarcoma proteomics
  • Gemdbj proteomics
  • Mass spectrometry
  • Proteome database
  • Two-dimensional difference gel electrophoresis (2d-dige)

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology
  • Computer Science Applications

Cite this

Proteome expression database of ewing sarcoma : A segment of the genome medicine database of Japan proteomics. / Kikuta, Kazutaka; Tsunehiro, Yukako; Yoshida, Akihiko; Tochigi, Naobumi; Hirohahsi, Setsuo; Kawai, Akira; Kondo, Tadashi.

In: Journal of Proteomics and Bioinformatics, Vol. 2, No. 12, 2009, p. 500-504.

Research output: Contribution to journalArticle

Kikuta, K, Tsunehiro, Y, Yoshida, A, Tochigi, N, Hirohahsi, S, Kawai, A & Kondo, T 2009, 'Proteome expression database of ewing sarcoma: A segment of the genome medicine database of Japan proteomics', Journal of Proteomics and Bioinformatics, vol. 2, no. 12, pp. 500-504. https://doi.org/10.4172/jpb.1000112
Kikuta, Kazutaka ; Tsunehiro, Yukako ; Yoshida, Akihiko ; Tochigi, Naobumi ; Hirohahsi, Setsuo ; Kawai, Akira ; Kondo, Tadashi. / Proteome expression database of ewing sarcoma : A segment of the genome medicine database of Japan proteomics. In: Journal of Proteomics and Bioinformatics. 2009 ; Vol. 2, No. 12. pp. 500-504.
@article{40afacdd9255410d9875c25bb2b3acb1,
title = "Proteome expression database of ewing sarcoma: A segment of the genome medicine database of Japan proteomics",
abstract = "Ewing sarcoma is the second most common primary malignant bone tumor in children and adolescents worldwide. Here, we report an open-access proteome expression database of eight Ewing sarcoma cases using proteome data obtained by two-dimensional difference gel electrophoresis (2D-DIGE) and mass spectrometry. Proteins extracted from primary tumor tissues were labeled with CyDye DIGE Fluor saturation dye, and separated using a large format electrophoresis device, generating 2431 protein spots. Mass spectrometry following in-gel digestion identified 330 protein spots corresponding to 220 proteins. Multiple proteins were observed from single protein spots, and single proteins generated multiple protein spots, suggesting diversity of the proteome observed by 2D-DIGE. The results of 2D-DIGE and protein identification by mass spectrometry, and part of the corresponding clinico-pathological data such as prognosis after treatments are freely accessible in the public proteome database Genome Medicine Database of Japan Proteomics (GeMDBJ Proteomics, https://gemdbj.nibio.go.jp/dgdb/DigeTop.do).",
keywords = "Ewing sarcoma proteomics, Gemdbj proteomics, Mass spectrometry, Proteome database, Two-dimensional difference gel electrophoresis (2d-dige)",
author = "Kazutaka Kikuta and Yukako Tsunehiro and Akihiko Yoshida and Naobumi Tochigi and Setsuo Hirohahsi and Akira Kawai and Tadashi Kondo",
year = "2009",
doi = "10.4172/jpb.1000112",
language = "English",
volume = "2",
pages = "500--504",
journal = "Journal of Proteomics and Bioinformatics",
issn = "0974-276X",
publisher = "Omics Publishing Group",
number = "12",

}

TY - JOUR

T1 - Proteome expression database of ewing sarcoma

T2 - A segment of the genome medicine database of Japan proteomics

AU - Kikuta, Kazutaka

AU - Tsunehiro, Yukako

AU - Yoshida, Akihiko

AU - Tochigi, Naobumi

AU - Hirohahsi, Setsuo

AU - Kawai, Akira

AU - Kondo, Tadashi

PY - 2009

Y1 - 2009

N2 - Ewing sarcoma is the second most common primary malignant bone tumor in children and adolescents worldwide. Here, we report an open-access proteome expression database of eight Ewing sarcoma cases using proteome data obtained by two-dimensional difference gel electrophoresis (2D-DIGE) and mass spectrometry. Proteins extracted from primary tumor tissues were labeled with CyDye DIGE Fluor saturation dye, and separated using a large format electrophoresis device, generating 2431 protein spots. Mass spectrometry following in-gel digestion identified 330 protein spots corresponding to 220 proteins. Multiple proteins were observed from single protein spots, and single proteins generated multiple protein spots, suggesting diversity of the proteome observed by 2D-DIGE. The results of 2D-DIGE and protein identification by mass spectrometry, and part of the corresponding clinico-pathological data such as prognosis after treatments are freely accessible in the public proteome database Genome Medicine Database of Japan Proteomics (GeMDBJ Proteomics, https://gemdbj.nibio.go.jp/dgdb/DigeTop.do).

AB - Ewing sarcoma is the second most common primary malignant bone tumor in children and adolescents worldwide. Here, we report an open-access proteome expression database of eight Ewing sarcoma cases using proteome data obtained by two-dimensional difference gel electrophoresis (2D-DIGE) and mass spectrometry. Proteins extracted from primary tumor tissues were labeled with CyDye DIGE Fluor saturation dye, and separated using a large format electrophoresis device, generating 2431 protein spots. Mass spectrometry following in-gel digestion identified 330 protein spots corresponding to 220 proteins. Multiple proteins were observed from single protein spots, and single proteins generated multiple protein spots, suggesting diversity of the proteome observed by 2D-DIGE. The results of 2D-DIGE and protein identification by mass spectrometry, and part of the corresponding clinico-pathological data such as prognosis after treatments are freely accessible in the public proteome database Genome Medicine Database of Japan Proteomics (GeMDBJ Proteomics, https://gemdbj.nibio.go.jp/dgdb/DigeTop.do).

KW - Ewing sarcoma proteomics

KW - Gemdbj proteomics

KW - Mass spectrometry

KW - Proteome database

KW - Two-dimensional difference gel electrophoresis (2d-dige)

UR - http://www.scopus.com/inward/record.url?scp=73649107329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73649107329&partnerID=8YFLogxK

U2 - 10.4172/jpb.1000112

DO - 10.4172/jpb.1000112

M3 - Article

AN - SCOPUS:73649107329

VL - 2

SP - 500

EP - 504

JO - Journal of Proteomics and Bioinformatics

JF - Journal of Proteomics and Bioinformatics

SN - 0974-276X

IS - 12

ER -